Lancet HIV Lancet HIV, Elsevier, 2016, 3 (1), pp.e23-e32. ⟨10.1016/S2352-3018(15)00211-8⟩ LANCET HIV The Lancet HIV, 3(1). Elsevier Europe PubMed Central The Lancet HIV, 3(1), e23-32. Elsevier Ltd. Mocroft, A, Lundgren, J D, Ross, M, Fux, C A, Reiss, P, Moranne, O, Morlat, P, Monforte, A DA, Kirk, O, Ryom, L, Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study & Pedersen, C 2016, ' Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate : a prospective international cohort study ', The Lancet HIV, vol. 3, no. 1, pp. e23-e32 . https://doi.org/10.1016/S2352-3018(15)00211-8 Lancet HIV, 3(1), e23-e32. Elsevier Limited The lancet HIV, 3(1), E23-E32. Elsevier Limited The Lancet HIV, 3, 1, pp. e23-32 The Lancet HIV, 3(1), E23-E32. ELSEVIER INC The Lancet HIV, 3, e23-32
AIDS (London, England), 25(12), 1505-1513. Lippincott Williams and Wilkins AIDS r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Kruk, A, Bannister, W, Podlekareva, D, Chentsova, N P, Rakhmanova, A G, Horban, A, Domingo, P, Mocroft, A, Lundgren, J, Kirk, O, EuroSIDA Study Group & Pedersen, C 2011, ' Tuberculosis among HIV-positive patients across Europe : changes over time and risk factors ', AIDS, vol. 25, no. 12, pp. 1505-13 . https://doi.org/10.1097/QAD.0b013e328348fafd